Profiling of virus-encoded microRNAs in epstein-barr virus- associated gastric carcinoma and their roles in gastric carcinogenesis

Journal of Virology

Volumn 89, Issue 10, 2015, Pages 5581-5591

  Shinozaki Ushiku, Aya ^a   Kunita, Akiko ^a   Isogai, Maya ^a   Hibiya, Takashi ^b   Ushiku, Tetsuo ^a   Takada, Kenzo ^c   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN BID; BID PROTEIN, HUMAN; VIRUS RNA;

3' UNTRANSLATED REGION; ADULT; AGED; APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOMA CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; FEMALE; GASTRIC CARCINOGENESIS; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; VIRUS GENE; ANIMAL; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; MOUSE; NUCLEOTIDE SEQUENCE; PATHOGENICITY; SCID MOUSE; STOMACH NEOPLASMS; TUMOR CELL LINE; VERY ELDERLY; VIROLOGY;

HUMAN HERPESVIRUS 4;

AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BASE SEQUENCE; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARCINOGENESIS; CELL LINE, TUMOR; DOWN-REGULATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MICE; MICE, SCID; MICRORNAS; MIDDLE AGED; RNA, VIRAL; STOMACH NEOPLASMS;

EID: 84928562455     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03639-14     Document Type: Article

References (40)

1. Kutok JL, Wang F. 2006. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1:375-404. http://dx.doi.org/10.1146/annurev.pathol.1.110304.100209.
2. Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S. 1993. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 143:1044-1049.
3. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757-768. http://dx.doi.org/10.1038/nrc1452.
4. Fukayama M, Hino R, Uozaki H. 2008. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci 99: 1726-1733. http://dx.doi.org/10.1111/j.1349-7006.2008.00888.x.
5. Young LS, Murray PG. 2003. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22:5108-5121. http://dx.doi.org/10.1038/sj.onc.1206556.
6. Kozomara A, Griffiths-Jones S. 2014. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42: D68-D73. http://dx.doi.org/10.1093/nar/gkt1181.
7. Shinozaki A, Sakatani T, Ushiku T, Hino R, Isogai M, Ishikawa S, Uozaki H, Takada K, Fukayama M. 2010. Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res 70:4719-4727. http://dx.doi.org/10.1158/0008-5472.CAN-09-4620.
8. Korpal M, Lee ES, Hu G, Kang Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283:14910-14914. http://dx.doi.org/10.1074/jbc.C800074200.
9. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. 2008. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68:7846-7854. http://dx.doi.org/10.1158/0008-5472.CAN-08-1942.
10. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601. http://dx.doi.org/10.1038/ncb1722.
11. Park SM, Gaur AB, Lengyel E, Peter ME. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the Ecadherin repressors ZEB1 and ZEB2. Genes Dev 22:894-907. http://dx.doi.org/10.1101/gad.1640608.
12. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T. 2004. Identification of virusencoded microRNAs. Science 304:734-736. http://dx.doi.org/10.1126/science.1096781.
13. Barth S, Meister G, Grasser FA. 2011. EBV-encoded miRNAs. Biochim Biophys Acta 1809:631-640. http://dx.doi.org/10.1016/j.bbagrm.2011.05.010.
14. Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, Toomey NL, Brites C, Dittmer DP, Harrington WJ, Jr. 2008. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68:1436-1442. http://dx.doi.org/10.1158/0008-5472.CAN-07-5126.
15. Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA. 2009. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83:2357-2367. http://dx.doi.org/10.1128/JVI.02104-08.
16. Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T, Tinguely M, Faggioni A, Trivedi P, Meister G, Renner C, Grasser FA. 2011. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res 39:1880-1893. http://dx.doi.org/10.1093/nar/gkq1043.
17. Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY. 2012. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 118:698-710. http://dx.doi.org/10.1002/cncr.26309.
18. Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS, Chen HC. 2010. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 5:e12745. http://dx.doi.org/10.1371/journal.pone.0012745.
19. Kim DN, Chae HS, Oh ST, Kang JH, Park CH, Park WS, Takada K, Lee JM, Lee WK, Lee SK. 2007. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81:1033-1036. http://dx.doi.org/10.1128/JVI.02271-06.
20. Lung RW, Tong JH, To KF. 2013. Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy. Int J Mol Sci 14:17378-17409. http://dx.doi.org/10.3390/ijms140917378.
21. Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA. 2011. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 7:e1002193. http://dx.doi.org/10.1371/journal.ppat.1002193.
22. Kim DN, Seo MK, Choi H, Kim SY, Shin HJ, Yoon AR, Tao Q, Rha SY, Lee SK. 2013. Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. J Gen Virol 94:497-506. http://dx.doi.org/10.1099/vir.0.045237-0.
23. Marquitz AR, Mathur A, Shair KH, Raab-Traub N. 2012. Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression. Proc Natl Acad Sci U S A 109:9593-9598. http://dx.doi.org/10.1073/pnas.1202910109.
24. Imai S, Nishikawa J, Takada K. 1998. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371-4378.
25. Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K. 1994. Epstein-Barr virusassociated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Investig 71:73-81.
26. Iwasaki Y, Chong JM, Hayashi Y, Ikeno R, Arai K, Kitamura M, Koike M, Hirai K, Fukayama M. 1998. Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J Virol 72:8321-8326.
27. Huang Da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. http://dx.doi.org/10.1038/nprot.2008.211.
28. Huang Da W, Sherman BT, Lempicki RA. 2009. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13. http://dx.doi.org/10.1093/nar/gkn923.
29. Marquitz AR, Mathur A, Nam CS, Raab-Traub N. 2011. The Epstein-Barr virus BART microRNAs target the pro-apoptotic protein Bim. Virology 412:392-400. http://dx.doi.org/10.1016/j.virol.2011.01.028.
30. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, Kwong DL, Tsao SW, Jin DY. 2008. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205:2551-2560. http://dx.doi.org/10.1084/jem.20072581.
31. Hino R, Uozaki H, Inoue Y, Shintani Y, Ushiku T, Sakatani T, Takada K, Fukayama M. 2008. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Cancer Res 68:1427-1435. http://dx.doi.org/10.1158/0008-5472.CAN-07-3027.
32. Nourse JP, Crooks P, Keane C, Nguyen-Van D, Mujaj S, Ross N, Jones K, Vari F, Han E, Trappe R, Fink S, Gandhi MK. 2012. Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffinembedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples. J Virol Methods 184:46-54. http://dx.doi.org/10.1016/j.jviromet.2012.05.005.
33. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. 2012. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31:2207-2221. http://dx.doi.org/10.1038/emboj.2012.63.
34. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Grasser F, Meister G. 2009. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83:3333-3341. http://dx.doi.org/10.1128/JVI.01689-08.
35. Motsch N, Alles J, Imig J, Zhu J, Barth S, Reineke T, Tinguely M, Cogliatti S, Dueck A, Meister G, Renner C, Grasser FA. 2012. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS One 7:e42193. http://dx.doi.org/10.1371/journal.pone.0042193.
36. Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, Sugden B. 2014. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 33:1258-1264. http://dx.doi.org/10.1038/onc.2013.71.
37. Choi H, Lee H, Kim SR, Gho YS, Lee SK. 2013. Epstein-Barr virusencoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol 87:8135-8144. http://dx.doi.org/10.1128/JVI.03159-12.
38. Chan JY, Gao W, Ho WK, Wei WI, Wong TS. 2012. Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma. Anticancer Res 32:3201-3210.
39. Gourzones C, Gelin A, Bombik I, Klibi J, Verillaud B, Guigay J, Lang P, Temam S, Schneider V, Amiel C, Baconnais S, Jimenez AS, Busson P. 2010. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J 7:271. http://dx.doi.org/10.1186/1743-422X-7-271.
40. Gourzones C, Ferrand FR, Amiel C, Verillaud B, Barat A, Guerin M, Gattolliat CH, Gelin A, Klibi J, Chaaben AB, Schneider V, Guemira F, Guigay J, Lang P, Jimenez-Pailhes AS, Busson P. 2013. Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients-evidence of nonexosomal transport. Virol J 10:119. http://dx.doi.org/10.1186/1743-422X-10-119.